Chemomab Therapeutics (CMMB) Q4 2022 Earnings

30MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.72
-0.49
-0.27
-0.04

Details

Expected EPS
N/A
Actual EPS
-0.72
Surprise EPS
-0.72
Surprise Percent
+∞%

Description

Chemomab Therapeutics (CMMB) has reported earnings of -0.72 per share for Q4 2022.

0 Comments

Share your thoughts